title: Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology.
authors.affiliation: Mood and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Bailey
authors.forename: Alexander
authors.initials: A
authors.lastname: Neumeister
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D043884:Receptor, Cannabinoid, CB1 / Q000819:agonists* / Q000502:physiology*; D012727:Sex Characteristics; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology*; D013315:Stress, Psychological / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D043884:Receptor, Cannabinoid, CB1